NCT06973798View on ClinicalTrials.gov

The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

October 20, 2025

Study Completion Date

November 10, 2025

Conditions
Kidney Neoplasms / SurgeryGlomerular Filtration RatePositron-Emission Tomography(PET)
Interventions
DIAGNOSTIC_TEST

GFR will be measured using three methods at two weeks before surgery and four ± one week after surgery

GFR will be measured using three methods at two weeks before surgery and four ± one week after surgery

DIAGNOSTIC_TEST

GFR will be measured using three methods: [68Ga]Ga-HBED-CC-DiAsp PET/CT, the Gates method, and the dual plasma sampling method with 99mTc-DTPA.

GFR will be measured using three methods: \[68Ga\]Ga-HBED-CC-DiAsp PET/CT, the Gates method, and the dual plasma sampling method with 99mTc-DTPA.

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

lead

Luo Yaping

OTHER